首页> 外国专利> APTAZYME SPECIFICALLY RELEASING ANTISENSE AGAINST MICRORNA IN HCV-INFECTED CELLS, AND USE THEREOF

APTAZYME SPECIFICALLY RELEASING ANTISENSE AGAINST MICRORNA IN HCV-INFECTED CELLS, AND USE THEREOF

机译:苯丙胺类药物可特定地减轻HCV感染细胞中微RNA的抗药性,并加以利用

摘要

The present invention relates to an aptazyme comprising an aptamer for a material encoded by Hepatitis C virus (HCV) RNA, to a hammerhead ribozyme which possesses, in a portion released by self-cleavage, antisense for microRNA, and to a communication module sequence which interconnects the aptamer and the hammerhead ribozyme, and which induces the self-cleavage activity of the hammerhead ribozyme when the material encoded by HCV RNA is bound to the aptamer. The aptazyme of the present invention exhibits the effect of inhibiting an activity of the microRNA specifically in cells in which HCVs proliferate, and therefore a composition containing the aptazyme according to the present invention may be valuably used in treating HCV-related diseases.
机译:本发明涉及一种适配子酶,其包含由丙型肝炎病毒(HCV)RNA编码的材料的适配子,涉及一种锤头状核酶,其在通过自我切割释放的部分中具有对microRNA的反义作用,并且涉及一种通信模块序列,将适体和锤头状核酶相互连接,当由HCV RNA编码的材料结合到适体上时,它会诱导锤头状核酶的自切割活性。本发明的aptazyme具有抑制HCV增殖的细胞中的微小RNA的活性的效果,因此,含有本发明aptazyme的组合物可以有效地用于治疗HCV相关疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号